Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
Authors
Keywords
-
Journal
Nature Biomedical Engineering
Volume 6, Issue 2, Pages 129-143
Publisher
Springer Science and Business Media LLC
Online
2022-01-11
DOI
10.1038/s41551-021-00831-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intratumoural administration and tumour tissue targeting of cancer immunotherapies
- (2021) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Stimuli-responsive transdermal microneedle patches
- (2021) Pooyan Makvandi et al. Materials Today
- Engineered immunogen binding to alum adjuvant enhances humoral immunity
- (2020) Tyson J. Moyer et al. NATURE MEDICINE
- Biomaterial scaffold-based local drug delivery systems for cancer immunotherapy
- (2020) Chen Yang et al. Science Bulletin
- Intratumoral Immunotherapy: from Trial Design to Clinical Practice
- (2020) Stephane Champiat et al. CLINICAL CANCER RESEARCH
- Localized Interleukin-12 for Cancer Immunotherapy
- (2020) Khue G. Nguyen et al. Frontiers in Immunology
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
- (2019) Noor Momin et al. Science Translational Medicine
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- Delivery strategies of cancer immunotherapy: recent advances and future perspectives
- (2019) Zhongwei Zhao et al. Journal of Hematology & Oncology
- Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters
- (2018) C. Burkart et al. GENE THERAPY
- A facile approach to enhance antigen response for personalized cancer vaccination
- (2018) Aileen Weiwei Li et al. NATURE MATERIALS
- Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
- (2018) Chun Gwon Park et al. Science Translational Medicine
- In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
- (2018) Chao Wang et al. Science Translational Medicine
- Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
- (2018) Ming Yi et al. Molecular Cancer
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- What, Why, Where, and When: Bringing Timing to Immuno-Oncology
- (2018) Adrienne M. Rothschilds et al. TRENDS IN IMMUNOLOGY
- Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
- (2018) Harm HogenEsch et al. npj Vaccines
- Is autoimmunity the Achilles' heel of cancer immunotherapy?
- (2017) Carl H June et al. NATURE MEDICINE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally
- (2016) M. Angela Aznar et al. JOURNAL OF IMMUNOLOGY
- Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
- (2016) Chao Wang et al. NANO LETTERS
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Case Report of Subcutaneous Nodules and Sterile Abscesses Due to Delayed Type Hypersensitivity to Aluminum-Containing Vaccines
- (2016) C. T. Lauren et al. PEDIATRICS
- Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer
- (2015) Sima Rahimian et al. BIOMATERIALS
- A Single Kinase Generates the Majority of the Secreted Phosphoproteome
- (2015) Vincent S. Tagliabracci et al. CELL
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients
- (2014) C Posch et al. BRITISH JOURNAL OF CANCER
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intratumoral Immunization: A New Paradigm for Cancer Therapy
- (2014) A. Marabelle et al. CLINICAL CANCER RESEARCH
- Murine leukemia virus envelope gp70 is a shared biomarker for the high-sensitivity quantification of murine tumor burden
- (2014) Francesca Scrimieri et al. OncoImmunology
- Collapse of the Tumor Stroma is Triggered by IL-12 Induction of Fas
- (2013) Sid P Kerkar et al. MOLECULAR THERAPY
- NK Cell-Derived Interferon-γ Orchestrates Cellular Dynamics and the Differentiation of Monocytes into Dendritic Cells at the Site of Infection
- (2012) Romina S. Goldszmid et al. IMMUNITY
- Secreted Kinase Phosphorylates Extracellular Proteins That Regulate Biomineralization
- (2012) V. S. Tagliabracci et al. SCIENCE
- Local Activation of CD8 T Cells and Systemic Tumor Eradication without Toxicity via Slow Release and Local Delivery of Agonistic CD40 Antibody
- (2011) M. F. Fransen et al. CLINICAL CANCER RESEARCH
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
- (2011) Sid P. Kerkar et al. JOURNAL OF CLINICAL INVESTIGATION
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12
- (2010) David A. Zaharoff et al. JOURNAL OF IMMUNOTHERAPY
- Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy
- (2009) Yuki Hori et al. BIOMATERIALS
- Intratumoral rhIL-12 administration in head and neck squamous cell carcinoma patients induces B cell activation
- (2008) Carla M.L. van Herpen et al. INTERNATIONAL JOURNAL OF CANCER
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
- (2008) Stephanie C. Eisenbarth et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started